237
Views
0
CrossRef citations to date
0
Altmetric
Original Research

CODE STEMI Program Improves Clinical Outcome in ST Elevation Myocardial Infarction Patients: A Retrospective Cohort Study

ORCID Icon, , , , , & ORCID Icon show all
Pages 315-321 | Published online: 02 Nov 2020

References

  • WHO. Non Communicable Diseases Country Profiles 2011. Vol. ISBN 978 9. Geneva; 2011.
  • Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors. J Am Coll Cardiol. 2019;74(20):2529 LP– 2532. doi:10.1016/j.jacc.2019.10.009.
  • Mandelzweig L, Battler A, Boyko V, et al. The second euro heart survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27(19):2285–2293.
  • Koh JQ, Tong DC, Sriamareswaran R, et al. In-hospital ‘CODE STEMI’’ improves door-to-balloon time in patients undergoing primary percutaneous coronary intervention. ‘ Emerg Med Australas. 2018;30(2):222–227. doi:10.1111/1742-6723.12855
  • Alyahya AA, Alghammass MA, Aldhahri FS, et al. The impact of introduction of Code-STEMI program on the reduction of door-to-balloon time in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A single-center study in Saudi Arabia. J Saudi Hear Assoc. 2018;30(3):172–179. doi:10.1016/j.jsha.2017.11.002
  • Rathore SS, Curtis JP, Chen J, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009;338:b1807. doi:10.1136/bmj.b1807
  • McNamara RL, Herrin J, Bradley EH, et al. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol. 2006;47(1):45–51. doi:10.1016/j.jacc.2005.04.071
  • McNamara RL, Herrin J, Wang Y, et al. Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2007;100(8):1227–1232. doi:10.1016/j.amjcard.2007.05.043
  • O’Gara PT, Frederick GK, Deborah DA, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary. Circulation. 2013;127(4):529–555. doi:10.1161/CIR.0b013e3182742c84.
  • McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006;47(11):2180–2186. doi:10.1016/j.jacc.2005.12.072
  • AlHabib KF, Sulaiman K, Al Suwaidi J, et al. Patient and system-related delays of emergency medical services use in acute ST-elevation myocardial infarction: results from the third gulf registry of acute coronary events (Gulf RACE-3Ps. PLoS One. 2016;11:1. doi:10.1371/journal.pone.0147385
  • Shiomi H, Nakagawa Y, Morimoto T, et al. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ. 2012;344:e3257. doi:10.1136/bmj.e3257
  • Le May M. Code STEMI: implementation of a city-wide program for rapid assessment and management of myocardial infarction. Can Med Assoc J. 2009;181(8):E136–-E137. doi:10.1503/cmaj.091087
  • De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223–1225. doi:10.1161/01.CIR.0000121424.76486.20
  • Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283(22):2941–2947. doi:10.1001/jama.283.22.2941
  • Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999;100(1):14–20. doi:10.1161/01.CIR.100.1.14
  • Vernon ST, Sean C, Mario D, et al. ST‐segment–elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their outcomes? J Am Heart Assoc. 2019;8(21):e013296. doi:10.1161/JAHA.119.013296
  • Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2004;26(1):18–26.